TECENTRIQ HYBREZA
Live / Applied — Statement of use — non-final action mailed (as of 02 Mar 2026)
What this means for you
Not registered yet, but its 18 May 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98002465
- Mark type
- Design + words
- Filed
- 18 May 2023
- Published for opposition
- 11 Jun 2024
- Attorney of record
- Jelena Libby
Goods and services
- Class 041 — Education and entertainment services: Education services, namely, providing courses, presentations, and training for patients and medical professionals, in the field of oncology, autoimmune, and inflammatory diseases and disorders; Providing online non-downloadable electronic publications in the nature of brochures in the field of oncology, autoimmune and inflammatory diseases and disorders
- Class 044 — Medical, beauty and agricultural services: Providing medical information in the field of oncology, autoimmune, and inflammatory diseases and disorders
Owner
- Genentech, Inc., South San Francisco, CA, US
- Genentech, Inc., South San Francisco, CA, US
Prosecution history
- 02 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 02 Mar 2026 — NON-FINAL ACTION E-MAILED
- 02 Mar 2026 — SU - NON-FINAL ACTION - WRITTEN
- 06 Feb 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 01 Aug 2025 — USE AMENDMENT FILED
- 06 Feb 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 01 Aug 2025 — TEAS STATEMENT OF USE RECEIVED
- 01 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Feb 2025 — SOU EXTENSION 1 GRANTED
- 01 Feb 2025 — SOU EXTENSION 1 FILED
- 31 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 06 Aug 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 11 Jun 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Jun 2024 — PUBLISHED FOR OPPOSITION
- 22 May 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED